Cargando…

Annual reports in medicinal chemistry. Volume 54 /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Neidle, Stephen
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cambridge, MA : Academic Press, 2020.
Colección:Issn Ser.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 SCIDIR_on1191684855
003 OCoLC
005 20231120010507.0
006 m o d
007 cr |n|||||||||
008 200831s2020 mau o 000 0 eng d
040 |a YDX  |b eng  |e pn  |c YDX  |d OPELS  |d OCLCF  |d EBLCP  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 1195467664 
020 |a 9780128210185  |q (electronic bk.) 
020 |a 0128210184  |q (electronic bk.) 
020 |z 9780128210178 
020 |z 0128210176 
035 |a (OCoLC)1191684855  |z (OCoLC)1195467664 
050 4 |a RS400 
082 0 4 |a 615.19  |2 23 
245 0 0 |a Annual reports in medicinal chemistry.  |n Volume 54 /  |c edited by Stephen Neidle. 
260 |a Cambridge, MA :  |b Academic Press,  |c 2020. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Issn Ser. 
505 0 |a Intro -- Quadruplex Nucleic Acids As Targets For Medicinal Chemistry -- Copyright -- Contents -- Contributors -- Preface -- Foreword -- References -- Part 1: Fundamentals of quadruplexes and their biology -- Chapter One: Fundamentals of G-quadruplex biology -- 1. Introduction -- 2. Experimental approaches to G-quadruplex biology -- 2.1. Some general principles and potential pitfalls -- 2.2. In silico approaches -- 2.3. Antibodies -- 2.4. Chromatin immunoprecipitation -- 2.5. Small molecules -- 2.6. Microscopy -- 2.7. Genetic approaches -- 3. Biological processes impacted by G-quadruplexes 
505 8 |a 3.1. Chromatin -- 3.2. Transcription -- 3.3. Messenger RNAs -- 3.4. Replication and genome stability -- 3.5. Telomeres -- 3.6. Mitochondria -- 3.7. Cancer -- 4. Closing remarks -- Acknowledgments -- References -- Chapter Two: Quadruplex structure and diversity -- 1. Structural elements of G-quadruplexes -- 1.1. G-tetrads -- 1.1.1. Individual component-G-tetrad configuration -- 1.1.2. Relational component-G-tetrad stacking interaction -- 1.1.3. Topological rules -- 1.2. G-columns -- 1.2.1. Individual component-G-column continuity -- 1.2.2. Relational component-G-column relative directionality 
505 8 |a 1.2.3. Topological rules -- 1.3. Loops -- 1.3.1. Individual component-Type of loops -- 1.3.2. Relational component-Peripheral structures -- 1.3.3. Topological rules -- 2. DNA G-quadruplexes -- 2.1. Canonical DNA G-quadruplexes -- 2.1.1. Parallel -- 2.1.2. Hybrid-Form 1 and form 2 -- 2.1.3. Anti-parallel-Chair and basket -- 2.2. Non-canonical DNA G-quadruplexes -- 2.2.1. Discontinuous G-columns -- 2.2.2. Peripheral structures -- 2.2.3. Left-handed G-column progressions -- 3. RNA G-quadruplexes -- 3.1. Canonical RNA G-quadruplex -- 3.2. Non-canonical RNA G-quadruplexes 
505 8 |a 3.2.1. FMRP-binding RNA aptamer -- 3.2.2. Spinach RNA aptamer and its derivatives -- 4. Conclusions -- References -- Part 2: Quadruplex targets in human and other organisms -- Chapter Three: Telomeric quadruplexes as therapeutic targets -- 1. Introduction -- 2. Telomere maintenance mechanisms and cancer -- 3. Structures of telomeric quadruplexes in vitro and in vivo -- 4. Ligand-based targeting of telomeric quadruplexes toward cancer therapy -- 5. Concluding remarks -- Acknowledgments -- References -- Chapter Four: Viral G-quadruplexes: New frontiers in virus pathogenesis and antiviral therapy 
505 8 |a 1. Introduction -- 2. DNA viruses -- 2.1. Herpesviruses -- 2.1.1. Alpha-herpesviruses -- 2.1.2. Beta-herpesviruses -- 2.1.2.1. Human cytomegalovirus -- 2.1.2.2. Human herpesviruses 6A/6B -- 2.1.3. Gamma-herpesviruses -- 2.1.3.1. Epstein-Barr virus -- 2.1.3.2. Kaposi�s sarcoma-associated herpesvirus -- 2.2. Other DNA viruses -- 2.2.1. Human papillomavirus -- 2.2.2. Hepatitis B virus -- 3. RNA viruses -- 3.1. Flaviviruses -- 3.1.1. ZIKA virus -- 3.1.2. Hepatitis C virus -- 3.2. Filoviruses -- 3.3. SARS coronavirus -- 4. Retroviruses -- 4.1. Lentiviruses -- 4.1.1. Human immunodeficiency virus type 1 
650 0 |a Clinical chemistry. 
650 0 |a Pharmaceutical chemistry. 
650 2 |a Chemistry, Clinical  |0 (DNLM)D002624 
650 2 |a Chemistry, Pharmaceutical  |0 (DNLM)D002626 
650 6 |a Chimie clinique.  |0 (CaQQLa)201-0016714 
650 6 |a Chimie pharmaceutique.  |0 (CaQQLa)201-0028674 
650 7 |a Clinical chemistry  |2 fast  |0 (OCoLC)fst00864330 
650 7 |a Pharmaceutical chemistry  |2 fast  |0 (OCoLC)fst01060115 
700 1 |a Neidle, Stephen. 
776 0 8 |i Print version:  |t Annual reports in medicinal chemistry. Volume 54.  |d Cambridge, MA : Academic Press, 2020  |z 0128210176  |z 9780128210178  |w (OCoLC)1139946336 
830 0 |a Issn Ser. 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/bookseries/00657743/54  |z Texto completo